Skip to main content
Top
Published in: BMC Geriatrics 1/2009

Open Access 01-12-2009 | Study protocol

Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: protocol for a prospective cohort study

Authors: Meg E Morris, Jennifer J Watts, Robert Iansek, Damien Jolley, Donald Campbell, Anna T Murphy, Clarissa L Martin

Published in: BMC Geriatrics | Issue 1/2009

Login to get access

Abstract

Background

Despite the finding that Parkinson disease (PD) occurs in more than one in every 1000 people older than 60 years, there have been few attempts to quantify how deficits in impairments, activity, participation, and quality of life progress in this debilitating condition. It is unclear which tools are most appropriate for measuring change over time in PD.

Methods and design

This protocol describes a prospective analysis of changes in impairments, activity, participation, and quality of life over a 12 month period together with an economic analysis of costs associated with PD. One-hundred participants will be included, provided they have idiopathic PD rated I-IV on the modified Hoehn & Yahr (1967) scale and fulfil the inclusion criteria. The study aims to determine which clinical and economic measures best quantify the natural history and progression of PD in a sample of people receiving services from the Victorian Comprehensive Parkinson's Program, Australia. When the data become available, the results will be expressed as baseline scores and changes over 3 months and 12 months for impairment, activity, participation, and quality of life together with a cost analysis.

Discussion

This study has the potential to identify baseline characteristics of PD for different Hoehn & Yahr stages, to determine the influence of disease duration on performance, and to calculate the costs associated with idiopathic PD. Valid clinical and economic measures for quantifying the natural history and progression of PD will also be identified.

Trial Registration

ACTRN12609000008224
Literature
1.
go back to reference Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM: Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007, 68 (5): 384-386. 10.1212/01.wnl.0000247740.47667.03.CrossRefPubMed Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM: Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007, 68 (5): 384-386. 10.1212/01.wnl.0000247740.47667.03.CrossRefPubMed
2.
go back to reference de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM: Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. Neurology. 2004, 63 (7): 1240-1244.CrossRefPubMed de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM: Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. Neurology. 2004, 63 (7): 1240-1244.CrossRefPubMed
4.
go back to reference Lindgren P, von Campenhausen S, Spottke E, Siebert U, Dodel R: Cost of Parkinson's disease in Europe. European Journal of Neurology. 2005, 12: 68-73. 10.1111/j.1468-1331.2005.01197.x.CrossRefPubMed Lindgren P, von Campenhausen S, Spottke E, Siebert U, Dodel R: Cost of Parkinson's disease in Europe. European Journal of Neurology. 2005, 12: 68-73. 10.1111/j.1468-1331.2005.01197.x.CrossRefPubMed
5.
go back to reference Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L: A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia. Journal of Clinical Neuroscience. 2006, 13 (6): 655-658. 10.1016/j.jocn.2005.09.006.CrossRefPubMed Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L: A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia. Journal of Clinical Neuroscience. 2006, 13 (6): 655-658. 10.1016/j.jocn.2005.09.006.CrossRefPubMed
6.
go back to reference Dodel RC, Singer M, Kahne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH: The Economic Impact of Parkinson's Disease: An Estimation Based on a 3-Month Prospective Analysis. PharmacoEconomics. 1998, 14 (3): 299-312. 10.2165/00019053-199814030-00006.CrossRefPubMed Dodel RC, Singer M, Kahne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH: The Economic Impact of Parkinson's Disease: An Estimation Based on a 3-Month Prospective Analysis. PharmacoEconomics. 1998, 14 (3): 299-312. 10.2165/00019053-199814030-00006.CrossRefPubMed
7.
go back to reference Findley L, Aujla M, Bain PG, Baker M, Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG, Peto V, Playfer JR: Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. Movement Disorders. 2003, 18 (10): 1139-1145. 10.1002/mds.10507.CrossRefPubMed Findley L, Aujla M, Bain PG, Baker M, Beech C, Bowman C, Holmes J, Kingdom WK, MacMahon DG, Peto V, Playfer JR: Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. Movement Disorders. 2003, 18 (10): 1139-1145. 10.1002/mds.10507.CrossRefPubMed
8.
go back to reference Hagell P, Nordling S, Reimer J, Grabowski M, Persson U: Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Movement Disorders. 2002, 17 (6): 1213-1220. 10.1002/mds.10262.CrossRefPubMed Hagell P, Nordling S, Reimer J, Grabowski M, Persson U: Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Movement Disorders. 2002, 17 (6): 1213-1220. 10.1002/mds.10262.CrossRefPubMed
9.
go back to reference Hallett M: Physiology of basal ganglia disorders: an overview. Can J Neurol Sci. 1993, 20 (3): 177-183.CrossRefPubMed Hallett M: Physiology of basal ganglia disorders: an overview. Can J Neurol Sci. 1993, 20 (3): 177-183.CrossRefPubMed
10.
go back to reference Berardelli A, Rothwell JC, Thompson PD, Hallett M: Pathophysiology of bradykinesia in Parkinson's disease. Brain. 2001, 124: 2131-2146. 10.1093/brain/124.11.2131.CrossRefPubMed Berardelli A, Rothwell JC, Thompson PD, Hallett M: Pathophysiology of bradykinesia in Parkinson's disease. Brain. 2001, 124: 2131-2146. 10.1093/brain/124.11.2131.CrossRefPubMed
11.
go back to reference Morris ME, Iansek R, Matyas TA, Summers JJ: The pathogenesis of gait hypokinesia in Parkinson's disease. Brain. 1994, 117 (Pt 5): 1169-1181. 10.1093/brain/117.5.1169.CrossRefPubMed Morris ME, Iansek R, Matyas TA, Summers JJ: The pathogenesis of gait hypokinesia in Parkinson's disease. Brain. 1994, 117 (Pt 5): 1169-1181. 10.1093/brain/117.5.1169.CrossRefPubMed
12.
go back to reference Brotchie P, Iansek R, Horne MK: Motor function of the monkey globus pallidus. Cognitive aspects of movement and phasic neuronal activity. Brain. 1991, 114 (Pt 4): 1685-1702. 10.1093/brain/114.4.1685.CrossRefPubMed Brotchie P, Iansek R, Horne MK: Motor function of the monkey globus pallidus. Cognitive aspects of movement and phasic neuronal activity. Brain. 1991, 114 (Pt 4): 1685-1702. 10.1093/brain/114.4.1685.CrossRefPubMed
13.
go back to reference Morris ME, Iansek R: Characteristics of motor disturbance in Parkinson's disease and strategies for movement rehabilitation. Journal of Human Movement Science. 1996, 15: 649-669. 10.1016/0167-9457(96)00020-6.CrossRef Morris ME, Iansek R: Characteristics of motor disturbance in Parkinson's disease and strategies for movement rehabilitation. Journal of Human Movement Science. 1996, 15: 649-669. 10.1016/0167-9457(96)00020-6.CrossRef
14.
go back to reference Iansek R: Pharmacological management of Parkinson's disease. Geriatric Therapeutics. 2004, 34: 229-232. Iansek R: Pharmacological management of Parkinson's disease. Geriatric Therapeutics. 2004, 34: 229-232.
15.
go back to reference Fahn S, Obeso JA, Olanow CW, Lang A, Tison E, Marion : The spectrum of levodopa-induced dyskinesias. Ann Neurol. 2000, 47 (4 Suppl 1): S2-S9.PubMed Fahn S, Obeso JA, Olanow CW, Lang A, Tison E, Marion : The spectrum of levodopa-induced dyskinesias. Ann Neurol. 2000, 47 (4 Suppl 1): S2-S9.PubMed
16.
go back to reference Kirkwood B: Occupational therapy for people with Parkinson's disease. Parkinson's disease: A team approach. Edited by: Morris M, Iansek R. 1997, Victoria: Biscombe Vicprint Kirkwood B: Occupational therapy for people with Parkinson's disease. Parkinson's disease: A team approach. Edited by: Morris M, Iansek R. 1997, Victoria: Biscombe Vicprint
17.
go back to reference Ellis T, de Goede C, Feldman RG, Wolters EC, Kwakkel G, Wagenaar RC: Efficacy of a physical therapy program in patients with Parkinson's disease: a randomised controlled trial. Archives of Physical Medicine & Rehabilitation. 2005, 86: 626-632. 10.1016/j.apmr.2004.08.008.CrossRef Ellis T, de Goede C, Feldman RG, Wolters EC, Kwakkel G, Wagenaar RC: Efficacy of a physical therapy program in patients with Parkinson's disease: a randomised controlled trial. Archives of Physical Medicine & Rehabilitation. 2005, 86: 626-632. 10.1016/j.apmr.2004.08.008.CrossRef
18.
go back to reference Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J: Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. Journal of Neurology, Neurosurgery & Psychiatry. 2003, 74: 158-162. 10.1136/jnnp.74.2.158.CrossRef Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J: Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. Journal of Neurology, Neurosurgery & Psychiatry. 2003, 74: 158-162. 10.1136/jnnp.74.2.158.CrossRef
19.
go back to reference Trend P, Kaye J, Gage H, Owen C, Wade DT: Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's diseas and their carers. Clinical Rehabilitation. 2002, 16: 717-725. 10.1191/0269215502cr545oa.CrossRefPubMed Trend P, Kaye J, Gage H, Owen C, Wade DT: Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's diseas and their carers. Clinical Rehabilitation. 2002, 16: 717-725. 10.1191/0269215502cr545oa.CrossRefPubMed
20.
go back to reference Morris ME: Impairments, activity limitations and participation restrictions in Parkinson's disease. Science-based rehabilitation: theories into practice. Edited by: Refshauge K, Ada L, Ellis E. 2005, Butterworth Heinemann: London Morris ME: Impairments, activity limitations and participation restrictions in Parkinson's disease. Science-based rehabilitation: theories into practice. Edited by: Refshauge K, Ada L, Ellis E. 2005, Butterworth Heinemann: London
21.
go back to reference de Goede CJ, Keus SH, Kwakkel G, Wagenaar RC: The effects of physical therapy in Parkinson's disease: a research synthesis. Arch Phys Med Rehabil. 2001, 82 (4): 509-515. 10.1053/apmr.2001.22352.CrossRefPubMed de Goede CJ, Keus SH, Kwakkel G, Wagenaar RC: The effects of physical therapy in Parkinson's disease: a research synthesis. Arch Phys Med Rehabil. 2001, 82 (4): 509-515. 10.1053/apmr.2001.22352.CrossRefPubMed
22.
go back to reference Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology. 1967, 17 (5): 427-442. 10.1159/000137111.CrossRefPubMed Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology. 1967, 17 (5): 427-442. 10.1159/000137111.CrossRefPubMed
23.
go back to reference Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G: Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism & Related Disorders. 2005, 11 (1): 19-24. 10.1016/j.parkreldis.2004.06.003.CrossRef Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G: Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism & Related Disorders. 2005, 11 (1): 19-24. 10.1016/j.parkreldis.2004.06.003.CrossRef
24.
go back to reference Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems AM, Kwakkel G, Van Wegen E: Attending to the task: Interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue and balance. Archives of Physical Medicine & Rehabilitation. 2004, 85: 1578-1585. 10.1016/j.apmr.2004.01.025.CrossRef Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems AM, Kwakkel G, Van Wegen E: Attending to the task: Interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue and balance. Archives of Physical Medicine & Rehabilitation. 2004, 85: 1578-1585. 10.1016/j.apmr.2004.01.025.CrossRef
25.
go back to reference Bloem BR, Bhatia KP: Gait and balance in basal ganglia disorders. Clinical Disorders of Balance, Posture, and Gait. Gait and balance in basal ganglia disorders. Edited by: Bronstein A, Brandt T, Woollacott M, Nutt JG. 2004, London: Arnold, 13-206. Bloem BR, Bhatia KP: Gait and balance in basal ganglia disorders. Clinical Disorders of Balance, Posture, and Gait. Gait and balance in basal ganglia disorders. Edited by: Bronstein A, Brandt T, Woollacott M, Nutt JG. 2004, London: Arnold, 13-206.
26.
go back to reference Marsden CD, Fahn S, (eds): Movement Disorders 2. 1987, London: Butterworth & Co. Ltd Marsden CD, Fahn S, (eds): Movement Disorders 2. 1987, London: Butterworth & Co. Ltd
27.
go back to reference Goetz CG, Stebbins GT, Shale HM: Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Movement Disorders. 1994, 9: 390-394. 10.1002/mds.870090403.CrossRefPubMed Goetz CG, Stebbins GT, Shale HM: Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Movement Disorders. 1994, 9: 390-394. 10.1002/mds.870090403.CrossRefPubMed
28.
go back to reference Peto V, Jenkinson C, Fitzpatrick R, Greenhall R: The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1967, 4 (3): 441-448. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R: The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1967, 4 (3): 441-448.
29.
go back to reference Podsiadlo D, Richardson S: The timed "Up & Go": a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society. 1991, 39 (2): 142-148.CrossRefPubMed Podsiadlo D, Richardson S: The timed "Up & Go": a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society. 1991, 39 (2): 142-148.CrossRefPubMed
Metadata
Title
Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: protocol for a prospective cohort study
Authors
Meg E Morris
Jennifer J Watts
Robert Iansek
Damien Jolley
Donald Campbell
Anna T Murphy
Clarissa L Martin
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2009
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-9-2

Other articles of this Issue 1/2009

BMC Geriatrics 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.